McHenry C R, Slusarczyk S J
Department of Surgery, MetroHealth Medical Center, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44109-1998, USA.
Surgery. 2000 Dec;128(6):994-8. doi: 10.1067/msy.2000.110242.
The purpose of this study was to characterize the hypothyroidism that occurs following hemithyroidectomy.
The records of all euthyroid patients who underwent hemithyroidectomy from 1992 to 2000 were reviewed to determine the frequency of postsurgical hypothyroidism and the predisposing factors. All patients were evaluated for age, gender, serum thyrotropin (TSH) levels, weight of resected thyroid tissue, and associated thyroiditis. Hypothyroid patients were evaluated for symptoms, timing of diagnosis, and treatment doses of levothyroxine (L-T(4)).
Hypothyroidism was diagnosed in 25 (35%) of 71 patients, subclinical in 16 and overt in 9 with a mean postoperative TSH level of 8.51 +/- 6.53 microIU/L. The mean preoperative TSH level was 1.94 +/- 1.00 microIU/L in hypothyroid compared with 1.10 +/- 0.74 microIU/L in euthyroid patients (P <.05). Lymphocytic thyroiditis was present in 10 (40%) of 25 hypothyroid compared with 10 (22%) of 46 euthyroid patients (P = not significant). There were no significant differences in age, gender, or weight of resected thyroid tissue. The average therapeutic dose of L-T(4) was 1.3 microg/kg (range, 0.5 to 1.9 microg/kg). All but 2 hypothyroid patients were diagnosed within 2 months of operation.
Hypothyroidism following hemithyroidectomy occurs in patients with higher preoperative TSH levels, is usually mild and asymptomatic, and can be treated with reduced doses of L-T(4).
本研究的目的是描述甲状腺半切术后发生的甲状腺功能减退症。
回顾1992年至2000年期间所有接受甲状腺半切术的甲状腺功能正常患者的记录,以确定术后甲状腺功能减退症的发生率及相关危险因素。对所有患者进行年龄、性别、血清促甲状腺激素(TSH)水平、切除甲状腺组织重量及相关甲状腺炎的评估。对甲状腺功能减退患者进行症状、诊断时间及左甲状腺素(L-T4)治疗剂量的评估。
71例患者中有25例(35%)被诊断为甲状腺功能减退症,其中亚临床型16例,显性型9例,术后TSH平均水平为8.51±6.53μIU/L。甲状腺功能减退患者术前TSH平均水平为1.94±1.00μIU/L,而甲状腺功能正常患者为1.10±0.74μIU/L(P<0.05)。25例甲状腺功能减退患者中有10例(40%)存在淋巴细胞性甲状腺炎,46例甲状腺功能正常患者中有10例(22%)存在(P=无显著性差异)。在年龄、性别或切除甲状腺组织重量方面无显著差异。L-T4的平均治疗剂量为1.3μg/kg(范围为0.5至1.9μg/kg)。除2例甲状腺功能减退患者外,所有患者均在术后2个月内确诊。
甲状腺半切术后甲状腺功能减退症发生于术前TSH水平较高的患者,通常症状轻微且无症状,可用较低剂量的L-T4进行治疗。